Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | 270,000 | N/A |
| Other Working Capital | N/A | N/A | N/A | -29,000 | N/A |
| Other Operating Activity | 0 | 0 | 0 | 140,000 | 0 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $381,000 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -175,000 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-175,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | N/A | N/A | -76,000 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 109,000 | 0 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $33,000 | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | 2,000 | N/A |
| Beginning Cash Position | N/A | N/A | N/A | 95,000 | N/A |
| End Cash Position | N/A | N/A | N/A | 336,000 | N/A |
| Net Cash Flow | $N/A | $N/A | $N/A | $241,000 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | 381,000 | N/A |
| Free Cash Flow | 0 | 0 | 0 | 381,000 | 0 |